@ryankshields

Husband. Father. Professional T-ball coach. Associate Professor of Medicine at University of Pittsburgh. Pharmacist-Scientist @IDPittStop #XDRLab

Joined September 2018
  • Tweets165
  • Following120
  • Followers1.3K
41Media
Ryan Shields retweeted
Cesar Arias@SuperBugDoc25 May 2021
Hot-off-the-press #AACJournal. Our latest article in the New Perspectives on Antimicrobial Agents section edited by @ryankshields . The focus is Cefiderocol written by a team of experts @ErinMcCreary @pranita_tamma @ASMicrobiology @ARLGnetwork aac.asm.org/content/early/20…
15
38
Ryan Shields retweeted
Cesar Arias@SuperBugDoc7 May 2021
#AACJournal podcast in Editors in Conversation series @ASMicrobiology now available! A great discussion with @pranita_tamma and Dr. Robert Bonomo on B-lactam/B-lactamase inhibitors. @ARLGnetwork asm.org/Podcasts/Editors-in-…

β-lactam/β-lactamase Inhibitor Combinations

How the discovery of β-lactam/β-lactam inhibitors has evolved.

asm.org
12
1
44
When you finish enrollment into a prospective beta-lactam TDM study as an ID fellow you get a cake and balloons! Congrats to @MDPharmDMVP and a huge thanks to the research team @IDPittStop ! Stay tuned for some really cool data in the months ahead....😎
2
2
68
Ryan Shields retweeted
Cesar Arias@SuperBugDoc6 Apr 2021
Hot off the press #AACJournal. Real world assesment of ceftolozane/tazobactam resistance in P. aeruginosa during therapy and its impact in other B-lactam/B-lactam inhibitors @ASMicrobiology, @ryankshields, @ARLGnetwork @davidvanduin . aac.asm.org/content/early/20…
1
20
2
47
Kudos to Abigail Rubio and our fantastic co-authors @DariaVanTyne @vscooper @ClancyNeil @mhn5pittedu1 @cleverwebber. C/T resistance most commonly mediated by ampC mutations leading to structural modifications, cross-R to CZA, and increased susceptibility to imipenem @IDPittStop
Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟
@ABsteward5 Apr 2021
🆕💥 #AAC @ASMicrobiology @ryankshields et Al @ClancyNeil @Ghastly In vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-emergent Resistance to Ceftolozane-tazobactam #IDTwitter aac.asm.org/content/early/20…
4
1
19
Great speakers for our upcoming TDM workshop and will be available for viewing on @CRE_REDUCE YouTube channel afterwards 👍@paulcritpharm @KathrynDaveson @hfzaziz2 @1darren1Dmr @GweeAmanda @turnidge @SuzieParker_CMG @JanJDeWaele @UQMedicine @UQHealth – at Brisbane, Queensland
CRE RESPOND
@CRE_RESPOND3 Nov 2020
Join @UQMedicine's Prof Roberts, Drs Suzie Parker, Andrew Burke, Claire Roger - Antimicrobial TDM Virtual Symposium Wed 11 Nov 2020. Register bit.ly/3emLy0S @jasonroberts_pk @padstamundo @Hendonet @EUCAST_EUCAST @turnidge @SuzieParker_CMG Thank you @pfizer_Au @MSD_Aus
8
2
31
Ryan Shields retweeted
Cesar Arias@SuperBugDoc2 Nov 2020
#AACJournal launches a new section: New Perspectives on Antimicrobial Agents, Edited by @ryankshields . Our first paper focuses on Remdesevir!
Francisco Marty, MD@FranciscoMarty_2 Nov 2020
🔥current, comprehensive review & perspective on #remdesivir for #COVID19 out in AAC! Special thanks to .@ryankshields & .@SuperBugDoc! Teamwork by: .@mmaleissa .@nyulangone student Emily Silverman .@LuisaParedesMD .@CameronNutt .@AaronRichterman link: aac.asm.org/content/early/20…
12
1
43
Launching the new AAC section in grand fashion! Stay tuned for more great content coming soon!
Francisco Marty, MD@FranciscoMarty_2 Nov 2020
🔥current, comprehensive review & perspective on #remdesivir for #COVID19 out in AAC! Special thanks to .@ryankshields & .@SuperBugDoc! Teamwork by: .@mmaleissa .@nyulangone student Emily Silverman .@LuisaParedesMD .@CameronNutt .@AaronRichterman link: aac.asm.org/content/early/20…
2
1
11
If you want a detailed review of treatment options, this is your source! 👇
Antibiotic Tweets@khalideljaaly23 Mar 2020
🔥🔥🔥 Excellent review of #COVIDー19 treatment options by outstanding ID pharmacists @jpogue1 @ErinMcCreary on behalf of @SIDPharm 💊🦠 academic.oup.com/ofid/advanc…
4
26
2
80
Wow! A surprising and unexpected finding from CRACKLE-2. Outcomes very similar for CPE and non-CPE infected patients! Same for unconfirmed CRE by phenotype 👀More to come in @TheLancetInfDis publication by @davidvanduin @SuperBugDoc et al. #AMRHouston2020
2
7
35
CRACKLE-2 data coming soon in @TheLancetInfDis over 1,000 patients with CRE!!! @davidvanduin #AMRHouston2020
5
1
10
Getting ready to kick off the AMR and stewardship conference in Houston chaired by @SuperBugDoc with a phenomenal agenda: gccamrjan2020.blogs.rice.edu…. Can’t wait! #AMRHouston2020
6
1
24
Ryan Shields retweeted
ESCMID@ESCMID21 Jan 2020
Abstract notifications are sent out. If you don't have yours yet, be patient...the server is working hard to process all those emails. For your convenience, this year we sent mails to the submitter and the presenting author as well!
17
22
23
82
Big day today for first year Med students at Pitt, they got to hear @ErinMcCreary drop some incredibly useful PK applications that connect basic pharmacology to the clinic. It was awesome! #startemyoung @IDPittStop
1
2
49
Ryan Shields retweeted
Monica Mahoney@mmPharmD10 Dec 2019
👇🏻 My attempt at live tweeting the live session and live streaming session 🤣 from Erin McCreary @ErinMcCreary and Sam Aitken @OncIDPharmd session at @ASHPOfficial #ASHP19 on resistant Gram negative infections/agents.
Monica Mahoney@mmPharmD10 Dec 2019
Did you make it into the hottest midday session, Seeing Red: Managing Multidrug Resistant Gram-Negative Infections? Easily met room capacity! @ProCEhealth Richard Lewis introducing @ErinMcCreary and @OncIDPharmd (Sam Aitken) @ASHPOfficial #ASHP19
1
4
20
Today is the day! If you can’t make it in person, join the webinar to hear rockstars @ErinMcCreary and @OncIDPharmd share their clinical experience and insights on managing MDR GNR infections!
SIDP@SIDPharm6 Dec 2019
Going to the @ASHPOfficial Midyear Meeting #ASHP19? Don't forget to register now for our co-sponsored program on MDR GNRs presented by @OncIDPharmd & @ErinMcCreary Attend at Midyear: conta.cc/3518I6U Attend via webinar: bit.ly/2qgj6sU #IDTwitter
2
12
39
Thread on @ASHPOfficial Midyear presentation for soon-to-be-released #vancomycin guidelines #ASHP19
Erin McCreary@ErinMcCreary8 Dec 2019
up bright and early to hear @IDpharmresearch, Dr. Jennifer Le, and Dr. Tom Lodise to go through the new #vancomycin guidelines at #ASHP19
8
1
26
up bright and early to hear @IDpharmresearch, Dr. Jennifer Le, and Dr. Tom Lodise to go through the new #vancomycin guidelines at #ASHP19
1
26
4
93
Load more